Skip to main content

Day: January 22, 2024

Chocolate Market Size Worth USD 161.99 Billion in 2032 | Emergen Research

Increasing demand for premium chocolates, growing awareness of the advantages of dark chocolate, and rising innovations in new chocolate products are some of the key factors driving Chocolate market revenue growth. Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global chocolate market size was USD 115.80 billion in 2022 and is expected to register a revenue CAGR of 3.4% during the forecast period. Increasing demand for premium chocolates, growing awareness of the advantages of dark chocolate, and rising innovations in new chocolate products are some of the key factors driving market revenue growth. Growing awareness of the advantages of dark chocolate is also a major factor driving market revenue growth. Nutrient-rich dark chocolate has a good impact on human health. Consuming dark chocolate with a high cocoa content in moderation...

Continue reading

Freddie Mac Multifamily Supports Over 423,000 Affordable Rental Units in 2023, on Track to Exceed Affordable Housing Goals

MCLEAN, Va., Jan. 22, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) Multifamily today announced its 2023 volume totaled over $49 billion, including $48.3 billion in multifamily financing and over $883 million in Low-Income Housing Tax Credit (LIHTC) equity investments. The company met its mission-driven affordable housing targets, supporting 423,177 affordable rental units across the United States. The Freddie Mac data released today indicates that the company will achieve all of its 2023 Multifamily affordable housing goals set by the Federal Housing Finance Agency (FHFA). A total of 66% of 2023 production volume qualified as “mission-driven affordable housing,” far exceeding the 50% goal set by FHFA. More than 67% of goal-eligible units financed through loan acquisitions were affordable to low-income residents earning less...

Continue reading

Heart Failure Drugs Market Size Worth USD 21.63 Billion in 2032 | Emergen Research

Increasing prevalence of heart failure, rising numbers of elderly individuals, increasing number of drugs in pipeline in developmental stages, and increase in risk factors associated with lifestyle choices are some of the key factors driving Heart Failure Drugs market revenue growth. Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global heart failure drugs market size was USD 12.20 Billion in 2022 and is expected to register a revenue CAGR of 5.9% during the forecast period. Increasing prevalence of heart failure, rising numbers of elderly individuals, increasing number of drugs in pipeline in developmental stages, and increase in risk factors associated with lifestyle choices are some of the key factors driving market revenue growth. Rising number of elderly individuals is also a key factor driving market revenue growth. When...

Continue reading

Invisible Orthodontics Market Size Worth USD 15.34 Billion in 2032 | Emergen Research

Increasing number of orthodontic issues, steady development of orthodontic technologies, and increasing awareness of the consequences of untreated dental misalignments are some of the key factors driving Invisible Orthodontics market revenue growth Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global invisible orthodontics market size was USD 4.14 Billion in 2022 and is expected to register a revenue CAGR of 14.0% during the forecast period. Increasing number of orthodontic issues, steady development of orthodontic technologies, the global proliferation of dental clinics and hospitals, and increasing awareness of the consequences of untreated dental misalignments are some of the key factors driving market revenue growth. Steady and continuous development of orthodontic technologies is a key factor driving market revenue growth....

Continue reading

Coronary Stents Products Market Size Worth USD 22.78 Billion in 2032 | Emergen Research

The steady market revenue growth can be attributed to increasing prevalence of cardiac disorders such as coronary artery disease (CAD) & heart failure, rising investments & funding toward production of such devices, and rapid advancements in angioplasty techniques. Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global coronary stents products market size was USD 11.09 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the forecast period. The steady market revenue growth can be attributed to increasing prevalence of cardiac disorders such as coronary artery disease (CAD) & heart failure, rising investments & funding toward production of such devices, and rapid advancements in angioplasty techniques. One of the major factors driving revenue growth of the market is increasing prevalence...

Continue reading

Kering: Monthly statement on the total number of shares and voting rights (January 2024)

Kering – Statement Number of Shares and voting rights – 15.01.2024 KeringSociété anonyme with a share capital of €493,683,112Head office: 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARIS    January 22, 2024   Monthly statementon the total number of shares and voting rights(articles L.233-8 of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers)Date     Total number ofshares   Total number of voting rightstheoretical 1 exercisable 2January 15, 2024 123,420,778 176,571,933 175,730,0611 Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulation). 2 Excluding treasury shares stripped of voting rights.AttachmentKering –...

Continue reading

Banco Comercial Português, S.A. (“Bank”) informs about communication received from Chiado (Luxembourg) S.À.R.L regarding the sale of Bank shares through an Accelerated Bookbuilding process

Banco Comercial Português, S.A. (“Bank”) informs about communication received from Chiado (Luxembourg) S.À.R.L regarding the sale of Bank shares through an Accelerated Bookbuilding processAttachment2024 01 22 ABB Fosun EN

Continue reading

RJD Green Inc.’s Management Discusses 2023 Calendar Year-End Results and 2024 Growth Focus

TULSA, OK, Jan. 22, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – RJD Green Inc. (OTCPK: RJDG) CEO Ron Brewer updates shareholders on 2023 calendar year-end results and targeted 2024 growth. Dear Valued RJD Green Shareholders, As we have finished our 2023 calendar year and are moving into the 2024 year, RJD Green’s management team would like to take the opportunity to update all existing and potential shareholders with the latest information on developments with the Company. Please be advised – this letter is not a substitute for reviewing our press releases and SEC filings. Some of this update is opinion – please note the forward-looking statements disclosure. We wanted to simplify the complexity and put our latest news items in context and keep you updated on our activities and events that may not rise to the level of a press...

Continue reading

Viscosupplementation Market Size Worth USD 10.51 Billion in 2032 | Emergen Research

Increasing number of patients suffering from osteoarthritis and popularity of minimum invasive procedures and rapid advancements in development of therapies using hyaluronic acid are key factors driving viscosupplementation market revenue growth. Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global viscosupplementation market size reached USD 4.41 Billion in 2022 and is expected to register a revenue CAGR of 9.1% during the forecast period. Increasing number of patients suffering from osteoarthritis and popularity of minimum invasive procedures and rapid advancements in development of therapies using hyaluronic acid are key factors driving market revenue growth.   In addition, increasing number of sports-related injuries is another key factor driving revenue growth of the market. According to the data published by National Institute...

Continue reading

Rovio Entertainment Corp.: Sega Europe Limited has gained title to the minority shares in Rovio Entertainment Corporation, and the Rovio shares will be delisted from Nasdaq Helsinki

Rovio Entertainment Corporation        Stock Exchange Release        January 22, 2024 at 6.30 p.m. EET Sega Europe Limited has gained title to the minority shares in Rovio Entertainment Corporation, and the Rovio shares will be delisted from Nasdaq Helsinki Sega Europe Limited (“Sega”) has posted a security approved by the arbitral tribunal appointed by the Redemption Board of the Finland Chamber of Commerce in connection with the redemption proceedings concerning the minority shares in Rovio Entertainment Corporation (“Rovio”). Sega has thus gained title to all the shares in Rovio in accordance with Chapter 18, Section 6 of the Finnish Companies Act. After the security has been posted and the title to the minority shares transferred, the minority shareholders of Rovio being parties to the redemption proceedings are only entitled to receive...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.